Literature DB >> 68820

Cytomegalovirus and cancer of the prostate: in vitro transformation of human cells.

L Geder, E J Sanford, T J Rohner, F Rapp.   

Abstract

Urogenital tissue specimens were maintained in culture for 2 years. Epithelioid growth was enhanced with use of collagenase digestion rather than trypsinization. Twenty of 34 prostate cancer cell cultures survived more than ten in vitro passages, during which time four of 20 demonstrated epithelioid morphology. One epithelioid line (T-157) survived 32 in vitro passages. The cells demonstrated lack of contact inhibition in culture, were slightly positive in acid phosphatase tests, and reacted positively with cytomegalovirus (CMV)-immune sera in indirect immunofluorescence (IF) tests. These cells, which were proven to be of human male origin, failed to yield infectious virus and could be re-isolated from a nodule induced by the cells when injected sc into weanling athymic nude mice. The serum of the patient from which the tumor cells were derived demonstrated high CMV antibody titers and reacted with the virus-specific membrane and intracellular antigens of CMV-transformed human cells in IF tests. A CMV strain isolated from one of the normal prostate cell cultures established an in vitro long-term persistent infection of human embryo lung cells which resulted in the development of two transformed cell lines. The transformed cells possessed CMV antigenic markers and induced non-differentiated tumors when transplanted into athymic nude mice. The results constitute further evidence of the transforming capacity of CMV, and suggest that the virus may be oncogenic in its natural (human) host.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 68820

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN: 0361-5960


  19 in total

Review 1.  Is HCMV a tumor promoter?

Authors:  Liliana Soroceanu; Charles S Cobbs
Journal:  Virus Res       Date:  2010-10-29       Impact factor: 3.303

2.  Prospective study of cytomegalovirus serostatus and prostate cancer risk in the Prostate Cancer Prevention Trial.

Authors:  Siobhan Sutcliffe; Cathee Till; Charlotte A Gaydos; Frank J Jenkins; Phyllis J Goodman; Ashraful M Hoque; Ann W Hsing; Ian M Thompson; Jonathan M Zenilman; William G Nelson; Angelo M De Marzo; Elizabeth A Platz
Journal:  Cancer Causes Control       Date:  2012-07-19       Impact factor: 2.506

3.  Transformation of NIH 3T3 cells with cloned fragments of human cytomegalovirus strain AD169.

Authors:  J A Nelson; B Fleckenstein; D A Galloway; J K McDougall
Journal:  J Virol       Date:  1982-07       Impact factor: 5.103

4.  Multiple transforming regions of human cytomegalovirus DNA.

Authors:  T el-Beik; A Razzaque; R Jariwalla; R L Cihlar; L J Rosenthal
Journal:  J Virol       Date:  1986-11       Impact factor: 5.103

5.  Tumor progression mediated by two cooperating DNA segments of human cytomegalovirus.

Authors:  R J Jariwalla; A Razzaque; S Lawson; L J Rosenthal
Journal:  J Virol       Date:  1989-01       Impact factor: 5.103

Review 6.  Cytomegalovirus in human brain tumors: Role in pathogenesis and potential treatment options.

Authors:  Cecilia Söderberg-Nauclér; John Inge Johnsen
Journal:  World J Exp Med       Date:  2015-02-20

7.  The association of viruses with urveal melanoma.

Authors:  D M Albert
Journal:  Trans Am Ophthalmol Soc       Date:  1979

8.  Study of antibodies to adenoviruses in patients with tumors of the urogenital system.

Authors:  S Csata; G Kulcsár; J Horváth; I Nász; J Ongrádi; A Verebélyi
Journal:  Int Urol Nephrol       Date:  1982       Impact factor: 2.370

9.  Elution of cytomegalovirus antibodies from adenocarcinoma of the colon.

Authors:  A Grail; M Norval
Journal:  Gut       Date:  1985-10       Impact factor: 23.059

10.  Persistent HCMV infection of a glioblastoma cell line contributes to the development of resistance to temozolomide.

Authors:  Pankaj Singh; Donna M Neumann
Journal:  Virus Res       Date:  2019-11-29       Impact factor: 3.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.